{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:18:30Z","timestamp":1790983110445,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,23]]},"DOI":"10.7759\/cureus.113228","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:25:16Z","timestamp":1784813116000},"source":"Crossref","is-referenced-by-count":1,"title":["Dupilumab-Induced Vitiligo Managed Effectively With Nemolizumab and Targeted Topical Therapy"],"prefix":"10.7759","author":[{"given":"Jessica","family":"Colon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Falabella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02519-4","article-title":"Atopic dermatitis","volume":"405","author":"Guttman-Yassky E","year":"2025","unstructured":"Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Atopic dermatitis. Lancet. 2025, 405:583-96. 10.1016\/S0140-6736(24)02519-4","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1449642","article-title":"Dupilumab for treatment of atopic dermatitis","volume":"11","author":"Seegr\u00e4ber M","year":"2018","unstructured":"Seegr\u00e4ber M, Srour J, Walter A, Knop M, Wollenberg A. Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol. 2018, 11:467-74. 10.1080\/17512433.2018.1449642","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.15564","article-title":"Two cases of dupilumab-induced vitiligo","volume":"22","author":"Ferreirinha A","year":"2024","unstructured":"Ferreirinha A, Sim\u00f5es Farinha P, Pessoa E Costa T, Duarte B. Two cases of dupilumab-induced vitiligo. J Dtsch Dermatol Ges. 2024, 22:1669-71. 10.1111\/ddg.15564","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v101.545","article-title":"Rapid enlargement of vitiligo vulgaris after initiation of dupilumab for atopic dermatitis: a case report","volume":"101","author":"Takeoka S","year":"2021","unstructured":"Takeoka S, Kamata M, Yokoi I, Takehara A, Tada Y. Rapid enlargement of vitiligo vulgaris after initiation of dupilumab for atopic dermatitis: a case report. Acta Derm Venereol. 2021, 101:adv00581. 10.2340\/actadv.v101.545","journal-title":"Acta Derm Venereol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.03.025","article-title":"Vitiligo during dupilumab therapy","volume":"36","author":"Picone V","year":"2023","unstructured":"Picone V, Napolitano M, Torta G, Fabbrocini G, Patruno C. Vitiligo during dupilumab therapy. JAAD Case Rep. 2023, 36:51-3. 10.1016\/j.jdcr.2023.03.025","journal-title":"JAAD Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19132","article-title":"Vitiligo induced by dupilumab treatment: a case series","volume":"37","author":"Ren H","year":"2023","unstructured":"Ren H, Akabane AL, Kelleher K, et al.. Vitiligo induced by dupilumab treatment: a case series. J Eur Acad Dermatol Venereol. 2023, 37:2259-61. 10.1111\/jdv.19132","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20279","article-title":"Interactions between dupilumab and vitiligo: a scoping review","volume":"39","author":"Mehta S","year":"2025","unstructured":"Mehta S, Metko D, Piguet V. Interactions between dupilumab and vitiligo: a scoping review. J Eur Acad Dermatol Venereol. 2025, 39:e280-2. 10.1111\/jdv.20279","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113741","article-title":"Regulation of skin barrier function via competition between AHR axis versus IL-13\/IL-4-JAK-STAT6\/STAT3 axis: pathogenic and therapeutic implications in atopic dermatitis","volume":"9","author":"Furue M","year":"2020","unstructured":"Furue M. Regulation of skin barrier function via competition between AHR axis versus IL-13\/IL-4-JAK-STAT6\/STAT3 axis: pathogenic and therapeutic implications in atopic dermatitis. J Clin Med. 2020, 9:3741. 10.3390\/jcm9113741","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.10950","article-title":"Roles of inflammation factors in melanogenesis (review)","volume":"21","author":"Fu C","year":"2020","unstructured":"Fu C, Chen J, Lu J, et al.. Roles of inflammation factors in melanogenesis (review). Mol Med Rep. 2020, 21:1421-30. 10.3892\/mmr.2020.10950","journal-title":"Mol Med Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2023.12.008","article-title":"JAK inhibitors for the treatment of vitiligo","volume":"113","author":"Inoue S","year":"2024","unstructured":"Inoue S, Suzuki T, Sano S, Katayama I. JAK inhibitors for the treatment of vitiligo. J Dermatol Sci. 2024, 113:86-92. 10.1016\/j.jdermsci.2023.12.008","journal-title":"J Dermatol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/516719-dupilumab-induced-vitiligo-managed-effectively-with-nemolizumab-and-targeted-topical-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:25:16Z","timestamp":1784813116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/516719-dupilumab-induced-vitiligo-managed-effectively-with-nemolizumab-and-targeted-topical-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.113228","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}